Lower 30-day readmission rates with roflumilast treatment among patients hospitalized for chronic obstructive pulmonary disease

BACKGROUND: Few data exist related to the impact of roflumilast on health care utilization. This retrospective study estimated 30-day hospital readmission rates between patients who did and did not use roflumilast among those with COPD hospitalizations. METHODS: Data were from MarketScan, a large US...

Descripción completa

Detalles Bibliográficos
Autores principales: Fu, Alex Z, Sun, Shawn X, Huang, Xingyue, Amin, Alpesh N
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2015
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4435078/
https://www.ncbi.nlm.nih.gov/pubmed/25999706
http://dx.doi.org/10.2147/COPD.S83082

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4435078/
https://www.ncbi.nlm.nih.gov/pubmed/25999706
http://dx.doi.org/10.2147/COPD.S83082

Ejemplares similares